Global Age Related Macular Degeneration Market Research Report Covers Historical Market Trends, Current Market Dynamics, Market Valuation by Segmentation as Well as Region, Country-level Analysis for Every Segment, Key Player’s Market Share Analysis, Competitive Landscape and Supply Chain Analysis.
Age-Related Macular Degeneration: Increasing cases of retinal disorders are likely to boost the global age-related macular degeneration market at a strong CAGR of 7.3% during the forecast period.
Some of the key players in the global age-related macular degeneration market are Novartis International AG (Switzerland), Alcon Vision Care (U.S.), Bayer AG (Germany), Acucela Inc. (U.S.), Neurotech Pharmaceuticals Inc., Ophthotech Corporation (U.S.), GlaxoSmithKline Plc (U.S.), Alimera sciences Inc. (U.S.), StemCell Inc. (Canada), F. Hoffmann-La Roche Ltd. (Switzerland), Regeneron Pharmaceutical Inc. (U.S.), Allergan Plc (Ireland), Adverum Biotechnologies Inc. (U.S.), Gilead Sciences Inc. (U.S.), Iconic Therapeutics Inc. (U.S.), Lpath Inc. (U.S.), OHR Pharmaceutical Inc. (U.S.), Bausch + Lomb (U.S.), Opthea Limited (Canada), PanOptica, Inc. (U.S.), Pfizer Inc. (U.S.), Neurotech Pharmaceuticals, Inc. (U.S.), Promedior, Inc. (U.S.), QLT Inc. (Canada), Quark (U.S.), Resolvyx Pharmaceuticals Inc. (U.S.), RXi Pharmaceuticals Inc. (U.S.), Sagent Pharmaceuticals, Inc. (U.S.), Santen Pharmaceutical Co., Ltd. (Japan), Sanwa Kagaku Kenkyusho (Japan), and others.
Get a FREE Sample with Complete TOC @ https://www.marketresearchfuture.com/sample_request/5736
Industry Segmentation
The global age-related macular degeneration market is segmented by type, drug, route of administration, treatment, and end-user.
On the basis of type, the global age-related macular degeneration market is segmented into dry age-related macular degeneration and wet age-related macular degeneration
On the basis of drug, the global age-related macular degeneration market is segmented into Eylea, Visudyne, Lucentis, Avastin, and others.
On the basis of route of administration, the global age-related macular degeneration market is segmented into intravenous, intravitreal, and others.
On the basis of treatment, the global age-related macular degeneration market is segmented into medications, devices, surgery, and others. The medication segment is further classified into anti-VEGF drugs, blood vessel growth inhibitors, vitamins, dietary supplements, and others. The devices segment is classified into corrective lenses, glasses, contact lenses, and others.
On the basis of end-user, the global age-related macular degeneration market is segmented into hospitals and diagnostic centers, clinics, academic research institutes, pharmaceutical and biotechnology companies, and others.
Intended Audience
- Medical Devices Companies
- Research and Development (R&D) Companies
- Pharmaceutical Companies
- Government Research Institutes
- Academic Institutes and Universities
Regional Analysis
The global Age-Related Macular Degeneration Market consists of regions, namely, the Americas, Europe, Asia Pacific, and the Middle East and Africa.
The Americas dominates the global age-related macular degeneration market owing to the increasing prevalence of Age-Related Macular Degeneration (AMD), growing awareness of AMD, and high rate of drug treatment. As per the American Academy of Ophthalmology, it was estimated that approximately 11 million Americans suffer from age-related macular degeneration and this number is projected to grow twofold to nearly 22 million by 2050. All these factors are fueling the growth of the North American age-related macular degeneration market.
Moreover, the European region is the second largest market for global age-related macular degeneration due to the increasing cases of eye disorders, rising initiatives by governmental and non-governmental organizations for patient assistance, and advancements in the medical procedure. Furthermore, the AMD is considered as the leading cause of adult blindness in developed countries.
Asia Pacific is the fastest growing region for the age-related macular degeneration market due to the increasing geriatric population, resulting in the occurrence of AMD.
The Middle Eastern and African region contributed the lowest share of the global age-related macular degeneration market. The prevalence of AMD is high in countries among South-East Asia and Sub-Saharan Africa due to Vitamin A Deficiency (VAD).
The Objective of the study:
- To provide a comprehensive analysis of the market scenario along with forecast of the various segments and sub-segments of the AMD market.
- To understand the historical growth of the market and forecast market revenue for the next five years.
- To provide country level analysis of the market with respect to the current market size and future prospective across North America, Europe, South America, the Middle East & Africa (MEA), Asia Pacific (APAC).
- To profile some of the top players operating in the market, comprehensively analyzing their core competencies, and drawing a competitive landscape for the market.
- The study offers a detailed market revenue estimation by analyzing; it on the basis of disease type, stages, age group, diagnosis & treatment, route of administration and end-user
Early Diners Are Offered Free Customization- Up to 20%
List of Tables
Table 1 Age-related Macular Degeneration Industry Synopsis, 2017–2023
Table 2 Age-related Macular Degeneration Market Estimates & Forecast, 2017–2023, (Usd Million)
Table 3 Age-related Macular Degeneration Market, by Region, 2017–2023, (Usd Million)
Table 4 Age-related Macular Degeneration Market, by Type, 2017–2023, (Usd Million)
Table 5 Age-related Macular Degeneration Market, by Drug, 2017–2023, (Usd Million)
Table 6 Age-related Macular Degeneration Market, by Route of Administration, 2017–2023, (Usd Million)
Table 7 Age-related Macular Degeneration Market, by Treatment, 2017–2023, (Usd Million)
Table 8 Age-related Macular Degeneration Market, by End-user, 2017–2023, (Usd Million)
Table 9 North America Age-related Macular Degeneration Market, by Type, 2017–2023, (Usd Million)
Table 10 North America Age-related Macular Degeneration Market, by Drug, 2017–2023, (Usd Million)
Continued…….
List of Figures
Figure 1 Research Process
Figure 2 Segmentation for Age-related Macular Degeneration Market
Figure 3 Segmentation Market Dynamics for Age-related Macular Degeneration Market
Figure 4 Global Age-related Macular Degeneration Market Share, by Type 2016
Figure 5 Global Age-related Macular Degeneration Market Share, by Drug 2016
Figure 6 Global Age-related Macular Degeneration Market Share, by Route of Administration, 2016
Figure 8 Global Age-related Macular Degeneration Market Share, by Treatment, 2016
Figure 9 Global Age-related Macular Degeneration Market Share, by End-user, 2016
Figure 10 Global Age-related Macular Degeneration Market Share, by Region, 2016
Continued…….
Ask for your specific company profile and country level customization on reports.
Get More Information on Age Related Macular Degeneration Market Research Report – Forecast to 2023 @ https://www.marketresearchfuture.com/reports/age-related-macular-degeneration-market-5736
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Edibles.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions